Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.267, 2000-01, pp. : 11-11
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
CHF DM programme prolongs survival but no cost savings
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 469, 2005-01 ,pp. :
Access to resources
Recommend
LifeMasters' DM programme helps contain claim costs in CHF patients
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 300, 2001-01 ,pp. :
Insulin analogues worth the extra cost in type 1 DM
Inpharma, Vol. 1, Iss. 1444, 2004-01 ,pp. :
Insulin analogues worth the extra cost in type 1 DM
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 456, 2004-01 ,pp. :
DM industry expresses interest in high-risk infant management
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 396, 2003-01 ,pp. :